Patient Blood Management and Treatment of Anemia in Critical Care

A review of the evidence

The lecture duration is 24min.

0.5 CPD Points, 0.5 CEUs, 0.5 CME credits approval pending.
Accredited by CPDUK, CBRN and Provider Pending.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Greg Hare
Professor of Anesthesia at the University of Toronto
Lecture Summary

The current presentation focuses on defining the magnitude of the problem of anemia, both globally and in perioperative and critically ill patients by assessing the prevalence of anemia, and its impact, on patients. Clinical studies that demonstrate a clear association between anemia and adverse outcomes including organ injury and mortality in surgical and critically ill patients. Strategies to prevent acute blood loss (eg. tranexamic acid) and to minimize the degree of anemia will be described in terms of their impact on reducing red blood cell transfusion and improved patient outcomes. The potential benefit of utilizing iron and erythrocyte stimulating agents to treat anemia in critically ill patients will be reviewed. Finally, an assessment of the optimal use of red blood cell transfusion in different patient populations, including critically ill patients will be discussed. In summary, anemia is prevalent; it can be effectively treated, and these treatments may improve the outcome and care of our patients.

Target Audience

Critical Care Doctors
Advanced Critical Care Nurse Practitioners

Learning Objectives:

Upon completion of this activity, you should be able to:

  • define the magnitude of the problem of anaemia
  • describe strategies to prevent acute blood loss
  • appraise the potential benefit of iron and erythrocyte stimulating agents to treat anaemia
  • assess the optimal use of red blood cell transfusion I'm different patient populations

None.